Therapeutic approaches in the treatment of vulvovaginal candidiasis

According to world statistics, vulvovaginal candidiasis is a very common disease with a serious tendency to recurrence and chronic-ity, which makes it a fundamentally significant medical and social problem, the solution of which is becoming a priority task facing obstetricians and gynecologists. The...

Full description

Bibliographic Details
Main Authors: A. Z. Khashukoeva, M. S. Safonina, G. O. Andreasyan, A. I. Myasoutova, A. V. Overko
Format: Article
Language:Russian
Published: Remedium Group LLC 2020-10-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/5798
_version_ 1797841299530842112
author A. Z. Khashukoeva
M. S. Safonina
G. O. Andreasyan
A. I. Myasoutova
A. V. Overko
author_facet A. Z. Khashukoeva
M. S. Safonina
G. O. Andreasyan
A. I. Myasoutova
A. V. Overko
author_sort A. Z. Khashukoeva
collection DOAJ
description According to world statistics, vulvovaginal candidiasis is a very common disease with a serious tendency to recurrence and chronic-ity, which makes it a fundamentally significant medical and social problem, the solution of which is becoming a priority task facing obstetricians and gynecologists. The attention of doctors should be focused on the search for optimal treatment regimens that meet all the requirements for therapeutic approaches, the introduction of which into clinical practice should lead to a significant decrease in the incidence of the disease and its chronicity in the population, and also on increase in the relapse interval, which will certainly be reflected in improving the quality of life of women. Analysis and comparison of the effectiveness of antifungal drugs on the modern pharmaceutical market, and the choice of the most effective and safe drug can be the key to success in combating the widespread prevalence of vulvovaginal candidiasis.The article presents the etiological aspects of vulvovaginal candidiasis, demonstrating an increase in the importance of Candida non-albicans in the pathogenesis of the disease, which is confirmed by high rates of disease prevalence, including chronic and recurrent forms. The mechanisms of vulvovaginal candidiasis development and diagnostic methods that allow to assess the state of vaginal microcenosis most adequately are considered. The negative impact of vulvovaginal candidiasis on the course of pregnancy and possible outcomes for both the mother and the fetus are also described. Special attention is paid to the ability of fungi of the genus Candida to form associations of microorganisms - biofilms, which create an obstacle to many antifungal drugs. The problem of resistance of Candida fungi to a number of antifungal drugs is highlighted. Data on the uniqueness of the composition and action of sertaconazole and the effectiveness of its use, which is confirmed by studies, including in a group of pregnant patients, are presented. The article analyses indicators of safety of sertaconazole and criteria of continuity.
first_indexed 2024-04-09T16:28:46Z
format Article
id doaj.art-90f4bbb2a8a34cdd8e169f673c1f01c2
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:28:46Z
publishDate 2020-10-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-90f4bbb2a8a34cdd8e169f673c1f01c22023-04-23T06:57:11ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902020-10-0101313814610.21518/2079-701X-2020-13-138-1465271Therapeutic approaches in the treatment of vulvovaginal candidiasisA. Z. Khashukoeva0M. S. Safonina1G. O. Andreasyan2A. I. Myasoutova3A. V. Overko4Pirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityRussian Clinical and Research Center of GerontologyPirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityAccording to world statistics, vulvovaginal candidiasis is a very common disease with a serious tendency to recurrence and chronic-ity, which makes it a fundamentally significant medical and social problem, the solution of which is becoming a priority task facing obstetricians and gynecologists. The attention of doctors should be focused on the search for optimal treatment regimens that meet all the requirements for therapeutic approaches, the introduction of which into clinical practice should lead to a significant decrease in the incidence of the disease and its chronicity in the population, and also on increase in the relapse interval, which will certainly be reflected in improving the quality of life of women. Analysis and comparison of the effectiveness of antifungal drugs on the modern pharmaceutical market, and the choice of the most effective and safe drug can be the key to success in combating the widespread prevalence of vulvovaginal candidiasis.The article presents the etiological aspects of vulvovaginal candidiasis, demonstrating an increase in the importance of Candida non-albicans in the pathogenesis of the disease, which is confirmed by high rates of disease prevalence, including chronic and recurrent forms. The mechanisms of vulvovaginal candidiasis development and diagnostic methods that allow to assess the state of vaginal microcenosis most adequately are considered. The negative impact of vulvovaginal candidiasis on the course of pregnancy and possible outcomes for both the mother and the fetus are also described. Special attention is paid to the ability of fungi of the genus Candida to form associations of microorganisms - biofilms, which create an obstacle to many antifungal drugs. The problem of resistance of Candida fungi to a number of antifungal drugs is highlighted. Data on the uniqueness of the composition and action of sertaconazole and the effectiveness of its use, which is confirmed by studies, including in a group of pregnant patients, are presented. The article analyses indicators of safety of sertaconazole and criteria of continuity.https://www.med-sovet.pro/jour/article/view/5798vulvovaginal candidiasisbiofilmspregnant womenantifungal drugssertaconazole
spellingShingle A. Z. Khashukoeva
M. S. Safonina
G. O. Andreasyan
A. I. Myasoutova
A. V. Overko
Therapeutic approaches in the treatment of vulvovaginal candidiasis
Медицинский совет
vulvovaginal candidiasis
biofilms
pregnant women
antifungal drugs
sertaconazole
title Therapeutic approaches in the treatment of vulvovaginal candidiasis
title_full Therapeutic approaches in the treatment of vulvovaginal candidiasis
title_fullStr Therapeutic approaches in the treatment of vulvovaginal candidiasis
title_full_unstemmed Therapeutic approaches in the treatment of vulvovaginal candidiasis
title_short Therapeutic approaches in the treatment of vulvovaginal candidiasis
title_sort therapeutic approaches in the treatment of vulvovaginal candidiasis
topic vulvovaginal candidiasis
biofilms
pregnant women
antifungal drugs
sertaconazole
url https://www.med-sovet.pro/jour/article/view/5798
work_keys_str_mv AT azkhashukoeva therapeuticapproachesinthetreatmentofvulvovaginalcandidiasis
AT mssafonina therapeuticapproachesinthetreatmentofvulvovaginalcandidiasis
AT goandreasyan therapeuticapproachesinthetreatmentofvulvovaginalcandidiasis
AT aimyasoutova therapeuticapproachesinthetreatmentofvulvovaginalcandidiasis
AT avoverko therapeuticapproachesinthetreatmentofvulvovaginalcandidiasis